Evidence-Based Content
Articles
Peer-reviewed insights, expert commentary, and evidence-based guidance on liver health, metabolic conditions, and cardiometabolic disease.
Submit Article10
Articles published
1
Editor's picks
Understanding Complexity. Shaping the Future. Why Liver & Heart.
By Ronald
I love complexity. But what does that have to do with human health, AI, and the way we build companies? More than you might think. Liver & Heart brings together my passion for technology, 25 years of building digital platforms, and a deeply personal motivation. Here's why I'm helping build it — and the vision behind it. Read my story in the article below.
Study on the changing global burden of liver cancer in the 21st century: more cases, new causes
By Liver & Heart Team
Liver cancer cases have risen worldwide since 2000. The study shows which causes are declining in importance and which are growing.
Review on early detection of liver scarring in fatty liver: new tests and better models of care
By Liver & Heart Team
Which tests detect liver scarring in fatty liver early, and how better cooperation between specialties can improve care.
EASL expert guidance on fatty liver (SLD): who gets tested where, and who treats how?
By Liver & Heart Team
How family doctors, metabolic clinics and liver specialists should work together on fatty liver: EASL recommendations.
Expert consensus for primary care: assessing and treating heart, kidney, liver and metabolic health together (CKLMS, fatty liver/MASLD)
By Liver & Heart Team
How family doctors can check heart, kidney, liver and metabolism together with simple tests: recommendations from an expert group.
Study on health policy on fatty liver (MASLD/MASH) in Europe: how well prepared are the countries?
By Liver & Heart Team
No national strategy in 28 countries: what a new analysis shows about how prepared Europe is for fatty liver.
Review of new treatment approaches for MASH (fatty liver inflammation): which drugs exist and who do they help?
By Liver & Heart Team
Resmetirom, semaglutide and other drugs: what a new review shows about treating fatty liver inflammation.
Review of care pathways for fatty liver (MASLD): how dangerous liver scarring is found early
By Liver & Heart Team
Nine studies with 8,551 people show that simple tests find liver scarring early, but only about half of those referred reach the specialist.
What is new in MASLD research 2026?
By Dr. Maurice Michel
International experts summarise key findings from the First Annual Paris International Liver Meeting 2026
Interview: Two Brothers, One Mission - Why Christoph and Maurice Michel Think Prevention Earlier and More Networked with Liver & Heart
FeaturedBy Liver & Heart Team
Two brothers, one mission: Christoph and Maurice Michel talk about how Liver & Heart is bringing a silent disease into the spotlight. Roughly one in three adults has fatty liver disease, yet liver, heart and metabolic health are still rarely considered together in care. Maurice explains why early detection matters, where the biggest gap in today's care lies, and how Liver & Heart aims to guide people from education through orientation to the right care.